The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
September 30th 2024
The guidelines mark a shift in practice by recommending a multimodal approach to opioid prescribing practices.
Nearly Half of US Physicians See Barriers to COVID-19 Vaccine Adoption
September 4th 2020In a survey of nearly 2000 physicians across 31 countries, nearly half of the physicians indicated that they see significant barriers to COVID-19 vaccine adoption for themselves and their adult patients.
Read More
Summary of Current SARS-CoV-2 Vaccine Trials
Many clinical trials are underway in a race to develop a safe and effective vaccine against severe acute respiratory SARS-CoV-2, the virus that causes COVID-19.
Read More
Granting Opportunities for Research and Collaboration in the Practice of Community Pharmacy
September 3rd 2020Pharmacy Times® interviewed Anne Marie Kondic, PharmD, on the grant opportunities the Community Pharmacy Foundation has supported to promote research and collaboration in the practice of the community pharmacy.
Watch
Study: Children With No COVID-19 Symptoms May Shed Virus for Weeks
September 2nd 2020The patients were identified for testing through contact tracing or by developing symptoms, with 22% never developing symptoms, 20% initially asymptomatic but developing symptoms later, and 58% being symptomatic at their initial test.
Read More
Survey Shows Community Pharmacists Are Mobile, Ready to Administer COVID-19 Vaccines
September 1st 2020A recent survey showed that 86% of community pharmacists plan to offer the COVID-19 vaccines once they become available, whereas another 12% responded that they want more information to determine their decision.
Read More
Opioid Prescription Rates Vary Following Knee Surgery, Higher Strength Doses Remain Common
August 31st 2020Investigators found that approximately 36% of the patients studied received a dosage strength of 250 mg of morphine over a 5-day period, above the CDC’s threshold for risky opioid prescribing.
Read More